Medical network - July 10 recently, Japan digital image technology giant Konica Minolta company (Konica Minolta) announced that will be $1 billion in cash for the American cancer genetic testing company Ambry Genetics.
It is reported, Ambry Genetics offers a variety of genetic and non-genetic disease detection, and including cancer, heart disease, lung disease, neurology and common genetic disease diagnosis. The company by the incumbent President Charles Dunlop and CEO Aaron Elliott jointly founded in 1999, has so far made more than 1 million cases of genetic testing, found in more than 45000 kinds of mutations in 500 genes.
Ambry Genetics product line
Konica minolta foreign announcement: through the acquisition, the company will set up its production capacity in the field of medical imaging, including high sensitivity test, immunohistochemical staining technique, means that the first step in the field of precision medical. Company plans to Ambry technology from Japan first, then the introduction of Europe.
Konica minolta President and CEO utilise Yamana said with Ambry, will be able to integrate a diagnostic technique based on genetic and biochemical detection, and applies the discovery of the medical profession into medicine, increase the ability of disease prevention, and effectively reduce the cost. This will not only become the foundation of the health care business for the company's future, and will power transformation of the mode of global health. It is reported, Konica Minolta will pay a $800 million advance payment first, capital contribution ratio of sixty percent, Konica Minolta Japan industry Innovation group (Innovation Network Corporation of Japan) forty percent.
Konica minolta has original parsing technology analysis of cellular proteins, but its main all-in-one business stagnated, through mergers and acquisitions (M&A) strengthen the focus on the development of medical and related business, to provide diagnostic services to the pharmaceutical companies and hospitals.
Cancer has become the first cause of death, Japanese early discovery and specific development become the topic. It is understood that this is the most expensive in the history of konica minolta, it reflects the slowdown in the printer business into the ambition in the field of health care.
In addition to the konica minolta, Japan many giant crossover into the medical field, such as: in 2015, nikon will Optos retinal imaging diagnosis instrument manufacturers in UK is a wholly owned subsidiary of; Canon in 2016 to about 660 billion yen to buy Toshiba medical systems; Fujifilm holdings in 2017 to about 150 billion yen to income its reagent pure drug manufacturers and light industry. |
